Inoviq Ltd (AU:IIQ) has released an update.
Biotech Capital Management Pty Ltd has emerged as a substantial holder in INOVIQ Limited, controlling 6.435% of the company’s ordinary shares. The firm acquired its stake on September 13, 2024, marking a significant move in the biotech investment landscape. The acquisition includes a portfolio of over 7 million ordinary shares managed through various entities and associates.
For further insights into AU:IIQ stock, check out TipRanks’ Stock Analysis page.
